INSIGHTS ON DRUG DEVELOPMENT

• Producing Quality APIs At Scale

  Targeted process optimization transformed an early‑phase API with yield and impurity challenges into a scalable, high‑quality manufacturing process ready to support ongoing drug development.

• Oral Solutions & Suspensions: The Art Of Pharmacy

  Oral liquid formulations improve accessibility and dosing flexibility. Learn how developers overcome stability, taste-masking, and manufacturing challenges.

• Assessing The Success Of CRISPR Gene Therapies Using ddPCR Technology

  Achieve high-fidelity results in gene therapy research. Discover how absolute quantification overcomes traditional limitations to provide the precision needed for validating CRISPR edits.

• 5 Hidden Risks In Early-Phase OSD Formulation Development

  Early formulation decisions in OSD development carry risks that may not surface until later stages, when the cost of course correction is significantly higher.

• Integrated LC/UV And LC/MS Workflows For Impurity And Degradation

  10/26/2026

  Fatty acid-modified GLP-1 peptides carry hydrophobicity and impurity profiles that strain separation. Pairing LC/UV with mass spectrometry exposes degradation and supplier-to-supplier differences.

• Screening For Amorphous Drug Substance

  5/6/2026

  Incorporate amorphous form screening early in development to unlock solubility advantages, improve bioavailability, and accelerate your path to market.

• An All-In-One Solution For Residual DNA Quantitation

  5/22/2025

  Explore an all-in-one solution for residual DNA quantitation with a 3D lab tour with virtual demos, videos, and interactive instrument guides to experience the full workflow.

• Microflow Columns Boost GLP-1 Sensitivity And Reduce Solvent

  5/7/2026

  Microflow chromatography offers a practical way to boost GLP‑1 assay sensitivity while cutting solvent use. See how 1.0 mm columns improve peak response without sacrificing chromatographic performance.

• Evaluating Compound Toxicity Effects On Healthy Intestinal Organoids

  3/24/2025

  3D organoids enhance drug toxicity prediction and are crucial for anti-cancer drug development. Examine a method using 3D mouse intestinal organoids that aims to provide vital data on intestinal toxicity.